Abstract
Aim: To determine whether modulation of T-cell responses by naturally occurring viral variants caused an increase in numbers of Tregs in HCV-infected patients. Patients, materials & methods: Human peripheral blood mononuclear cells, having proliferative responses to a wild-type HCV-specific CD4 + T-cell epitope, were used to quantify, via proliferative assays, flow cytometry and class II tetramers, the effects of naturally occurring viral variants arising in the immunodominant epitope. Results: In combination, the wild-type and variant peptides led to enhanced suppression of an anti-HCV T-cell response. The variant had a lower avidity for the wild-type-specific CD4 + T cell. Variant-stimulated CD4+ T cells had increased Foxp3, compared with wild-type-stimulated cells. Conclusion: A stable viral variant from a chronic HCV subject was able to induce Tregs in multiple individuals that responded to the wild-type HCV-specific CD4+ T-cell epitope.
Original language | English (US) |
---|---|
Pages (from-to) | 695-705 |
Number of pages | 11 |
Journal | Future Virology |
Volume | 8 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2013 |
Keywords
- HCV
- altered peptide ligand
- human PBMCs
- regulatory T cells
ASJC Scopus subject areas
- Virology